| Description | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More | Radioimmunoassay (RIA) for the determination of human free anti-insulin antibodies (AIA) in serum and plasma. FDA exempt, can be used for in-vitro diagnostics. | Solid phase sandwich ELISA for the determination of BACE1 in human, mouse or rat brain extracts or cultured cell lysate. For research use only, not for use in diagnostic procedures. | The Influenza Virus A IgG ELISA is intended for the qualitative determination of IgG class antibodies against Influenza Virus A in human serum or plasma (citrate, heparin). FDA exempt, can be used for in-vitro diagnostics. | Solid phase competitive enzyme immunoassay (ELISA) for the determination of free Triiodothyronine (fT3) in human serum. FDA exempt, can be used for in-vitro diagnostics. |